IMUC
Price
$0.07
Change
-$0.03 (-30.00%)
Updated
Jun 27 closing price
Capitalization
8.49M
STTK
Price
$0.81
Change
-$0.11 (-11.96%)
Updated
Jun 30, 04:08 PM (EDT)
Capitalization
40.89M
38 days until earnings call
Interact to see
Advertisement

IMUC vs STTK

Header iconIMUC vs STTK Comparison
Open Charts IMUC vs STTKBanner chart's image
EOM Pharmaceutical Holdings
Price$0.07
Change-$0.03 (-30.00%)
Volume$115
Capitalization8.49M
Shattuck Labs
Price$0.81
Change-$0.11 (-11.96%)
Volume$600
Capitalization40.89M
IMUC vs STTK Comparison Chart in %
Loading...
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUC vs. STTK commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUC is a Hold and STTK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (IMUC: $0.07 vs. STTK: $0.92)
Brand notoriety: IMUC and STTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUC: 43% vs. STTK: 2321%
Market capitalization -- IMUC: $8.49M vs. STTK: $40.89M
IMUC [@Biotechnology] is valued at $8.49M. STTK’s [@Biotechnology] market capitalization is $40.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUC’s FA Score shows that 1 FA rating(s) are green whileSTTK’s FA Score has 1 green FA rating(s).

  • IMUC’s FA Score: 1 green, 4 red.
  • STTK’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMUC and STTK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUC’s TA Score shows that 1 TA indicator(s) are bullish while STTK’s TA Score has 2 bullish TA indicator(s).

  • IMUC’s TA Score: 1 bullish, 4 bearish.
  • STTK’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, IMUC is a better buy in the short-term than STTK.

Price Growth

IMUC (@Biotechnology) experienced а -35.67% price change this week, while STTK (@Biotechnology) price change was -4.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Reported Earning Dates

STTK is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STTK($40.9M) has a higher market cap than IMUC($8.49M). STTK YTD gains are higher at: -24.190 vs. IMUC (-60.249). STTK has more cash in the bank: 60.9M vs. IMUC (85.3K).
IMUCSTTKIMUC / STTK
Capitalization8.49M40.9M21%
EBITDAN/A-71.12M-
Gain YTD-60.249-24.190249%
P/E Ratio0.02N/A-
RevenueN/A4.61M-
Total Cash85.3K60.9M0%
Total DebtN/A3.19M-
FUNDAMENTALS RATINGS
IMUC: Fundamental Ratings
IMUC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMUCSTTK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLOFF0.170.01
+7.11%
Talon Metals Corp.
WTBFB290.931.93
+0.67%
W.T.B. Financial Corp.
FMFG16.75N/A
N/A
Farmers and Merchants Bancshares, Inc.
OGFGF6.92N/A
N/A
Origin Energy Ltd.
NCTKY9.18N/A
N/A
Nabtesco Corp.

IMUC and

Correlation & Price change

A.I.dvisor tells us that IMUC and ANEB have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMUC and ANEB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUC
1D Price
Change %
IMUC100%
-34.02%
ANEB - IMUC
23%
Poorly correlated
+2.11%
VNDA - IMUC
22%
Poorly correlated
-0.83%
STTK - IMUC
21%
Poorly correlated
-8.27%
CCCC - IMUC
21%
Poorly correlated
-7.89%
BLUE - IMUC
9%
Poorly correlated
N/A
More

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with ACAD. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
-8.27%
ACAD - STTK
40%
Loosely correlated
-0.41%
VRTX - STTK
36%
Loosely correlated
-0.47%
ADCT - STTK
35%
Loosely correlated
+0.37%
NAUT - STTK
35%
Loosely correlated
-12.57%
STRO - STTK
31%
Poorly correlated
-8.14%
More